Clinical Trials Browser

Phase 2 × Recurrence × Cilengitide × Clear all

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

Glioblastoma, Recurrence

NCT01517776 2015-07-21

HGG-CilMetro

Phase 2 Terminated

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Recurrence